JP2009528987A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009528987A5 JP2009528987A5 JP2008553534A JP2008553534A JP2009528987A5 JP 2009528987 A5 JP2009528987 A5 JP 2009528987A5 JP 2008553534 A JP2008553534 A JP 2008553534A JP 2008553534 A JP2008553534 A JP 2008553534A JP 2009528987 A5 JP2009528987 A5 JP 2009528987A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- yeast
- influenza
- antigen
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims 41
- 239000000203 mixture Substances 0.000 claims 36
- 108090000623 proteins and genes Proteins 0.000 claims 36
- 102000004169 proteins and genes Human genes 0.000 claims 36
- 239000000427 antigen Substances 0.000 claims 31
- 102000036639 antigens Human genes 0.000 claims 31
- 108091007433 antigens Proteins 0.000 claims 31
- 206010022000 influenza Diseases 0.000 claims 25
- 241000712461 unidentified influenza virus Species 0.000 claims 25
- 108010059722 Viral Fusion Proteins Proteins 0.000 claims 21
- 230000003834 intracellular effect Effects 0.000 claims 14
- 108090001074 Nucleocapsid Proteins Proteins 0.000 claims 12
- 230000002163 immunogen Effects 0.000 claims 11
- 101710154606 Hemagglutinin Proteins 0.000 claims 10
- 102000005348 Neuraminidase Human genes 0.000 claims 10
- 108010006232 Neuraminidase Proteins 0.000 claims 10
- 101710093908 Outer capsid protein VP4 Proteins 0.000 claims 10
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 claims 10
- 101710176177 Protein A56 Proteins 0.000 claims 10
- 108020001507 fusion proteins Proteins 0.000 claims 8
- 102000037865 fusion proteins Human genes 0.000 claims 8
- 239000000185 hemagglutinin Substances 0.000 claims 8
- 210000004027 cell Anatomy 0.000 claims 6
- 244000052769 pathogen Species 0.000 claims 6
- 108090000862 Ion Channels Proteins 0.000 claims 5
- 102000004310 Ion Channels Human genes 0.000 claims 5
- 238000002360 preparation method Methods 0.000 claims 4
- 101800001707 Spacer peptide Proteins 0.000 claims 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims 3
- 230000001717 pathogenic effect Effects 0.000 claims 3
- 241000235648 Pichia Species 0.000 claims 2
- 241000235070 Saccharomyces Species 0.000 claims 2
- 101001039853 Sonchus yellow net virus Matrix protein Proteins 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 108700010900 influenza virus proteins Proteins 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 101800001415 Bri23 peptide Proteins 0.000 claims 1
- 101800000655 C-terminal peptide Proteins 0.000 claims 1
- 102400000107 C-terminal peptide Human genes 0.000 claims 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims 1
- 108010041986 DNA Vaccines Proteins 0.000 claims 1
- 229940021995 DNA vaccine Drugs 0.000 claims 1
- 102000002067 Protein Subunits Human genes 0.000 claims 1
- 108010001267 Protein Subunits Proteins 0.000 claims 1
- 241000235346 Schizosaccharomyces Species 0.000 claims 1
- 239000000284 extract Substances 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 230000036039 immunity Effects 0.000 claims 1
- 230000003053 immunization Effects 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 claims 1
- 230000004481 post-translational protein modification Effects 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 229940031626 subunit vaccine Drugs 0.000 claims 1
- 210000005253 yeast cell Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76502506P | 2006-02-02 | 2006-02-02 | |
| US60/765,025 | 2006-02-02 | ||
| PCT/US2007/061572 WO2007092792A2 (en) | 2006-02-02 | 2007-02-02 | Yeast-based vaccine for inducing an immune response |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012260860A Division JP2013075899A (ja) | 2006-02-02 | 2012-11-29 | 治療用組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009528987A JP2009528987A (ja) | 2009-08-13 |
| JP2009528987A5 true JP2009528987A5 (https=) | 2010-04-02 |
| JP5198290B2 JP5198290B2 (ja) | 2013-05-15 |
Family
ID=38345897
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008553534A Expired - Fee Related JP5198290B2 (ja) | 2006-02-02 | 2007-02-02 | 免疫反応を誘発する酵母ベースワクチン |
| JP2012260860A Pending JP2013075899A (ja) | 2006-02-02 | 2012-11-29 | 治療用組成物 |
| JP2014230982A Withdrawn JP2015038147A (ja) | 2006-02-02 | 2014-11-13 | 免疫反応を誘発する酵母ベースワクチン |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012260860A Pending JP2013075899A (ja) | 2006-02-02 | 2012-11-29 | 治療用組成物 |
| JP2014230982A Withdrawn JP2015038147A (ja) | 2006-02-02 | 2014-11-13 | 免疫反応を誘発する酵母ベースワクチン |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US7736642B2 (https=) |
| EP (2) | EP1988919A4 (https=) |
| JP (3) | JP5198290B2 (https=) |
| KR (2) | KR20140029551A (https=) |
| CN (2) | CN101405026B (https=) |
| AU (1) | AU2007212076B2 (https=) |
| BR (1) | BRPI0706913A2 (https=) |
| CA (1) | CA2638815A1 (https=) |
| IL (2) | IL193196A (https=) |
| IN (1) | IN2014DN08830A (https=) |
| MX (1) | MX2008009929A (https=) |
| SG (2) | SG169375A1 (https=) |
| TW (2) | TW200806316A (https=) |
| WO (1) | WO2007092792A2 (https=) |
Families Citing this family (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002225681A1 (en) * | 2000-11-15 | 2002-05-27 | Globe Immune, Inc. | Yeast-dentritic cell vaccines and uses thereof |
| KR101455222B1 (ko) * | 2002-12-16 | 2014-10-31 | 글로브이뮨 | 면역 요법으로서의 효모계 백신 |
| US8343502B2 (en) * | 2002-12-16 | 2013-01-01 | Globeimmune, Inc. | Yeast-based vaccines as immunotherapy |
| SG163572A1 (en) * | 2005-07-11 | 2010-08-30 | Globeimmune Inc | Compositions and methods for eliciting an immune response to escape mutants of targeted therapies |
| US20070172503A1 (en) | 2005-12-13 | 2007-07-26 | Mycologics,Inc. | Compositions and Methods to Elicit Immune Responses Against Pathogenic Organisms Using Yeast Based Vaccines |
| US7736642B2 (en) * | 2006-02-02 | 2010-06-15 | Globeimmune, Inc. | Yeast-based vaccine for inducing an immune response |
| GB0613977D0 (en) | 2006-02-07 | 2006-08-23 | Peptcell Ltd | Peptide sequences and compositions |
| WO2007130330A2 (en) * | 2006-05-01 | 2007-11-15 | Technovax, Inc. | Polyvalent influenza virus-like particle (vlp) compositions |
| EP1998814A4 (en) * | 2006-05-11 | 2010-06-16 | Novavax Inc | NEW VACCINES AGAINST INFLUENZA M2 |
| WO2008054540A2 (en) * | 2006-05-18 | 2008-05-08 | Pharmexa Inc. | Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions |
| WO2008097863A2 (en) * | 2007-02-02 | 2008-08-14 | Globeimmune, Inc. | Methods for producing yeast-based vaccines |
| US8501167B2 (en) * | 2007-03-19 | 2013-08-06 | Globeimmune, Inc. | Compositions and methods for targeted ablation of mutational escape of targeted therapies for cancer |
| US20100285050A1 (en) | 2007-10-05 | 2010-11-11 | Isis Innovation Limited | Compositions and Methods |
| GB0719526D0 (en) * | 2007-10-05 | 2007-11-14 | Isis Innovation | Compositions and methods |
| WO2010036948A2 (en) * | 2008-09-26 | 2010-04-01 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Dna prime/inactivated vaccine boost immunization to influenza virus |
| MX2011010977A (es) | 2009-04-17 | 2012-02-29 | Us Health | Composiciones inmunoterapeuticas combinadas contra cancer y metodos. |
| AU2010250780A1 (en) * | 2009-05-18 | 2012-01-12 | Panacea Biotec Ltd | Universal influenza vaccine based on recombinant modified vaccinia Ankara virus (MVA) |
| CA2774326C (en) | 2009-09-14 | 2023-11-07 | Donald Bellgrau | Modulation of yeast-based immunotherapy products and responses |
| WO2012006561A2 (en) * | 2010-07-08 | 2012-01-12 | New York Medical College | Influenza virus detection and diagnosis |
| JP6029586B2 (ja) * | 2010-10-04 | 2016-11-24 | マサチューセッツ インスティテュート オブ テクノロジー | 血球凝集素ポリペプチド、ならびにそれに関連する試薬および方法 |
| WO2012048817A2 (en) * | 2010-10-15 | 2012-04-19 | Bavarian Nordic A/S | Recombinant modified vaccinia virus ankara influenza vaccine |
| US9254320B2 (en) * | 2010-12-17 | 2016-02-09 | Globeimmune, Inc. | Compositions and methods for the treatment or prevention of human adenovirus-36 infection |
| WO2012106231A2 (en) | 2011-01-31 | 2012-08-09 | Baxter International Inc. | Recombinant viral vectors and methods for inducing a heterosubtypic immune response to influenza a viruses |
| JP5745102B2 (ja) | 2011-02-12 | 2015-07-08 | グローブイミューン，インコーポレイテッド | 慢性ｂ型肝炎感染症のための酵母系免疫療法組成物 |
| MX350661B (es) | 2011-03-17 | 2017-09-13 | Us Health | Composiciones inmunoterapeuticas de levadura-brachyuri. |
| WO2012162342A2 (en) * | 2011-05-23 | 2012-11-29 | The Wistar Institute Of Anatomy And Biology | Influenza vaccines containing modified adenovirus vectors |
| CN103732250A (zh) | 2011-06-14 | 2014-04-16 | 全球免疫股份有限公司 | 基于酵母的治疗或预防丁型肝炎病毒感染的组合物和方法 |
| US9580475B2 (en) * | 2011-06-20 | 2017-02-28 | University of Pittsburgh—of the Commonwealth System of Higher Education | Computationally optimized broadly reactive antigens for H1N1 influenza |
| SG10201607663YA (en) | 2011-08-17 | 2016-11-29 | Globeimmune Inc | Yeast-muc1 immunotherapeutic compositions and uses thereof |
| ES2525205T3 (es) | 2011-11-09 | 2014-12-18 | Werner Lubitz | Vacuna para su uso en inmunoterapia tumoral |
| DE102011121069A1 (de) | 2011-12-13 | 2013-06-13 | Martin-Luther-Universität Halle-Wittenberg | Vakzinierung mittels rekombinanter Hefe durch Erzeugung einer protektiven humoralen Immunantwort gegen definierte Antigene |
| MX365418B (es) | 2012-06-26 | 2019-06-03 | Biodesix Inc | Metodo por espectros de masa para la seleccion y descarte de pacientes de cancer para el tratamiento con terapias generadoras de respuestas inmunitarias. |
| US9744193B2 (en) | 2012-09-06 | 2017-08-29 | Orbis Health Solutions Llc | Tumor lysate loaded particles |
| JP5954079B2 (ja) | 2012-09-25 | 2016-07-20 | ソニー株式会社 | 培養観察装置及び培養観察方法 |
| EP2929351B1 (en) * | 2012-12-10 | 2019-10-09 | The University of Queensland | Cell-free biofragment compositions and related systems, devices, and methods |
| KR20150128900A (ko) * | 2013-03-15 | 2015-11-18 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | 항원 및 어쥬번트로서 인터류킨-23을 갖는 백신 |
| AU2014265873B2 (en) | 2013-03-19 | 2019-01-17 | Globeimmune, Inc. | Yeast-based immunotherapy for chordoma |
| TWI626948B (zh) | 2013-03-26 | 2018-06-21 | 環球免疫公司 | 治療或預防人類免疫缺乏病毒感染之組合物及方法 |
| JP2014210747A (ja) * | 2013-04-19 | 2014-11-13 | アンジェスＭｇ株式会社 | 細胞性免疫誘導能が改善された経口ワクチン |
| US10226522B2 (en) | 2013-08-30 | 2019-03-12 | Globeimmune, Inc. | Compositions and methods for the treatment or prevention of tuberculosis |
| US10835595B2 (en) | 2014-01-06 | 2020-11-17 | The Trustees Of The University Of Pennsylvania | PD1 and PDL1 antibodies and vaccine combinations and use of same for immunotherapy |
| US10166195B2 (en) | 2014-03-05 | 2019-01-01 | Orbis Health Solutions, Llc | Vaccine delivery systems using yeast cell wall particles |
| CA2948803A1 (en) | 2014-04-11 | 2015-10-15 | Globeimmune, Inc. | Yeast-based immunotherapy and type i interferon sensitivity |
| CN105233302B (zh) * | 2014-07-10 | 2018-10-19 | 中国人民解放军军事医学科学院生物工程研究所 | 一种流感血凝素糖蛋白多聚物纳米颗粒的制备方法 |
| AU2016205208A1 (en) | 2015-01-09 | 2017-07-06 | Etubics Corporation | Methods and compositions for ebola virus vaccination |
| WO2016168187A1 (en) * | 2015-04-13 | 2016-10-20 | The Regents Of The University Of Michigan | Virus-like particles |
| AU2016303525B2 (en) | 2015-08-03 | 2021-01-21 | Globeimmune, Inc. | Modified yeast-Brachyury immunotherapeutic compositions |
| JP6956067B2 (ja) * | 2015-08-11 | 2021-10-27 | オービス ヘルス ソリューションズ エルエルシー | 細菌およびウイルスのワクチン戦略 |
| GB2552441A (en) * | 2015-10-22 | 2018-01-31 | Royal Veterinary College | Methods |
| EP3195878A1 (en) | 2016-01-22 | 2017-07-26 | Werner Lubitz | Bacterial ghosts for the treatment of cancer |
| KR20180117227A (ko) | 2016-03-24 | 2018-10-26 | 난트셀, 인크. | 네오에피토프 제시를 위한 시퀀스들 및 시퀀스 배열들 |
| US11779637B2 (en) | 2017-04-24 | 2023-10-10 | Nantcell, Inc. | Targeted neoepitope vectors and methods therefor |
| CA3086456A1 (en) | 2017-12-21 | 2019-06-27 | Kirin Holdings Kabushiki Kaisha | Cross-immunizing antigen vaccine and method for preparation thereof |
| DE102017012109A1 (de) | 2017-12-27 | 2019-06-27 | Martin-Luther-Universität Halle-Wittenberg | Optimiertes Wirts-/Vektorsystem zur Erzeugung protektiver mono- und multivalenter subunit-Vakzine auf Basis der Hefe Kluyveromyces lactis |
| CN119818663A (zh) | 2018-05-15 | 2025-04-15 | 全球免疫公司 | 用于诱导细胞免疫应答的重组酵母裂解物 |
| CN111315407B (zh) * | 2018-09-11 | 2023-05-02 | 上海市公共卫生临床中心 | 一种广谱抗流感疫苗免疫原及其应用 |
| US20210290708A1 (en) | 2018-09-21 | 2021-09-23 | Nantcell, Inc. | Methods and compositions for modulating myeloid-derived suppressor cells |
| JP2022532922A (ja) * | 2019-05-21 | 2022-07-20 | エスペロバックス インコーポレイティド | 酵母ベースの経口ワクチン接種 |
| EP4103722A4 (en) * | 2020-02-11 | 2024-05-22 | Cytonus Therapeutics, Inc. | RAPID VACCINE PLATFORM |
| US20210284716A1 (en) | 2020-03-11 | 2021-09-16 | Immunitybio, Inc. | ACE2-Fc Trap |
| US12285480B2 (en) | 2020-03-11 | 2025-04-29 | Nantcell, Inc. | Method of inducing immunity against SARS-CoV-2 using spike and nucleocapsid-ETSD immunogens delivered by RNA and replication-defective adenoviruses |
| US11857620B2 (en) | 2020-03-11 | 2024-01-02 | Immunitybio, Inc. | Method of inducing immunity against SARS-CoV-2 using spike (s) and nucleocapsid (N)-ETSD immunogens delivered by a replication-defective adenovirus |
| AU2021254753A1 (en) | 2020-04-14 | 2022-08-25 | Nantcell, Inc. | Yeast lysate COVID-19 vaccine |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5830463A (en) * | 1993-07-07 | 1998-11-03 | University Technology Corporation | Yeast-based delivery vehicles |
| US5413914A (en) | 1993-07-07 | 1995-05-09 | The Regents Of The University Of Colorado | Yeast assay to identify inhibitors of dibasic amino acid processing endoproteases |
| JPH09511381A (ja) * | 1994-01-11 | 1997-11-18 | ブラームス・インターユニバージテーア・インスティテュート・ボーア・ビーオテクノロジー | インフルエンザワクチン |
| US5691189A (en) * | 1994-01-19 | 1997-11-25 | Bristol-Myers Squibb Company | Saccharomyces cerevisiae expressing M2 protein of influenza A virus |
| US6696251B1 (en) * | 1996-05-31 | 2004-02-24 | Board Of Trustees Of The University Of Illinois | Yeast cell surface display of proteins and uses thereof |
| US20020044948A1 (en) * | 2000-03-15 | 2002-04-18 | Samir Khleif | Methods and compositions for co-stimulation of immunological responses to peptide antigens |
| MXPA02012254A (es) * | 2000-06-23 | 2003-04-25 | American Cyanamid Co | Montaje de particulas quimericas semejantes al virus de influenza y del tipo silvestre. |
| AU2002225681A1 (en) | 2000-11-15 | 2002-05-27 | Globe Immune, Inc. | Yeast-dentritic cell vaccines and uses thereof |
| US20030008000A1 (en) * | 2001-03-08 | 2003-01-09 | Wong Jonathan P. | DNA vaccine using liposome-encapsulated plasmid DNA encoding for hemagglutinin protein of influenza virus |
| US20030202982A1 (en) * | 2001-08-15 | 2003-10-30 | Birkett Ashley J. | Influenza immunogen and vaccine |
| KR101455222B1 (ko) * | 2002-12-16 | 2014-10-31 | 글로브이뮨 | 면역 요법으로서의 효모계 백신 |
| US7439042B2 (en) * | 2002-12-16 | 2008-10-21 | Globeimmune, Inc. | Yeast-based therapeutic for chronic hepatitis C infection |
| US8592197B2 (en) * | 2003-07-11 | 2013-11-26 | Novavax, Inc. | Functional influenza virus-like particles (VLPs) |
| JP5331340B2 (ja) * | 2004-05-18 | 2013-10-30 | バイカル インコーポレイテッド | インフルエンザウィルスワクチン組成物、及びその使用方法 |
| AU2005284727A1 (en) * | 2004-09-17 | 2006-03-23 | University Of Massachusetts | Compositions and their uses for lysosomal enzyme deficiencies |
| US7736642B2 (en) * | 2006-02-02 | 2010-06-15 | Globeimmune, Inc. | Yeast-based vaccine for inducing an immune response |
-
2007
- 2007-02-02 US US11/670,902 patent/US7736642B2/en not_active Expired - Fee Related
- 2007-02-02 CN CN200780009861.4A patent/CN101405026B/zh not_active Expired - Fee Related
- 2007-02-02 IN IN8830DEN2014 patent/IN2014DN08830A/en unknown
- 2007-02-02 TW TW096103976A patent/TW200806316A/zh unknown
- 2007-02-02 SG SG201100779-6A patent/SG169375A1/en unknown
- 2007-02-02 TW TW102144486A patent/TW201412329A/zh unknown
- 2007-02-02 CA CA002638815A patent/CA2638815A1/en not_active Withdrawn
- 2007-02-02 KR KR1020147004408A patent/KR20140029551A/ko not_active Withdrawn
- 2007-02-02 BR BRPI0706913-8A patent/BRPI0706913A2/pt not_active Application Discontinuation
- 2007-02-02 KR KR20087020923A patent/KR101492524B1/ko not_active Ceased
- 2007-02-02 MX MX2008009929A patent/MX2008009929A/es active IP Right Grant
- 2007-02-02 WO PCT/US2007/061572 patent/WO2007092792A2/en not_active Ceased
- 2007-02-02 EP EP07717549A patent/EP1988919A4/en not_active Withdrawn
- 2007-02-02 EP EP11180828.3A patent/EP2468296A3/en not_active Withdrawn
- 2007-02-02 AU AU2007212076A patent/AU2007212076B2/en not_active Ceased
- 2007-02-02 CN CN201510122553.9A patent/CN104826102A/zh not_active Withdrawn
- 2007-02-02 JP JP2008553534A patent/JP5198290B2/ja not_active Expired - Fee Related
- 2007-02-02 SG SG10201402236VA patent/SG10201402236VA/en unknown
-
2008
- 2008-07-31 IL IL193196A patent/IL193196A/en active IP Right Review Request
-
2010
- 2010-04-16 US US12/762,221 patent/US20100196411A1/en not_active Abandoned
-
2012
- 2012-11-29 JP JP2012260860A patent/JP2013075899A/ja active Pending
-
2014
- 2014-05-08 IL IL232518A patent/IL232518A0/en unknown
- 2014-11-13 JP JP2014230982A patent/JP2015038147A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009528987A5 (https=) | ||
| Freyn et al. | A multi-targeting, nucleoside-modified mRNA influenza virus vaccine provides broad protection in mice | |
| Pardi et al. | Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses | |
| US11938221B2 (en) | Multivalent nanoparticle-based vaccines | |
| Wohlbold et al. | Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses | |
| IL193196A (en) | Vaccine comprising a yeast vehicle and an influenza virus fusion protein | |
| Gerhard et al. | Prospects for universal influenza virus vaccine | |
| Song et al. | Influenza virus-like particles containing M2 induce broadly cross protective immunity | |
| Branco et al. | Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever | |
| Deng et al. | M2e-based universal influenza A vaccines | |
| Gao et al. | Enhanced Influenza VLP vaccines comprising matrix-2 ectodomain and nucleoprotein epitopes protects mice from lethal challenge | |
| Kim et al. | Multiple heterologous M2 extracellular domains presented on virus-like particles confer broader and stronger M2 immunity than live influenza A virus infection | |
| Arunkumar et al. | Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice | |
| Lee et al. | Mechanisms of cross-protection by influenza virus M2-based vaccines | |
| Deliyannis et al. | Induction of long-term memory CD8+ T cells for recall of viral clearing responses against influenza virus | |
| HRP20171213T1 (hr) | Glikoproteinske čestice nalik virusu (vlp) bjesnoće | |
| Stepanova et al. | Flagellin-fused protein targeting M2e and HA2 induces potent humoral and T-cell responses and protects mice against various influenza viruses a subtypes | |
| Epstein | Universal influenza vaccines: progress in achieving broad cross-protection in vivo | |
| JP2014507144A5 (ja) | 慢性ｂ型肝炎感染症のための酵母系免疫療法組成物 | |
| Du et al. | Flu universal vaccines: new tricks on an old virus | |
| Bolduc et al. | The quest for a nanoparticle-based vaccine inducing broad protection to influenza viruses | |
| Yong et al. | Development of virus‐like particles‐based vaccines against coronaviruses | |
| Hoxie et al. | A recombinant N2 neuraminidase-based CpG 1018® adjuvanted vaccine provides protection against challenge with heterologous influenza viruses in mice and hamsters | |
| Prokopenko et al. | Truncation of NS1 protein enhances T cell-mediated cross-protection of a live attenuated influenza vaccine virus expressing wild-type nucleoprotein | |
| Feng et al. | Baculovirus surface display of SARS coronavirus (SARS-CoV) spike protein and immunogenicity of the displayed protein in mice models |